Allarity Therapeutics, Inc. (ALLR) stock
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84−0.03 (-3.91%)
Close on Nov 17, 2026Market cap $13.38MP/E –Yield –
Allarity Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Allarity Therapeutics's total debt was $20.86M at Jun 30, 2026. For fiscal 2025 it was $0, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2023 | Dec 31, 2023 | $250.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $20.86M | – |
| Q1 FY2026 | Mar 31, 2026 | $20.08M | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $250.00K | – |
See a number that looks wrong?